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Résumé en
anglais
BACKGROUND: The dysfunction of OPA1, a dynamin GTPase involved in
mitochondrial fusion, is responsible for a large spectrum of neurological disorders,
each of which includes optic neuropathy. The database dedicated to OPA1 (
https://www.lovd.nl/OPA1 [21] ), created in 2005, has now evolved towards a
centralized and more reliable database using the Global Variome shared Leiden
Open-source Variation Database (LOVD) installation.
RESULTS: The updated OPA1 database, which registers all the patients from our
center as well as those reported in the literature, now covers a total of 831 patients:
697 with isolated dominant optic atrophy (DOA), 47 with DOA "plus", and 83 with
asymptomatic or unclassified DOA. It comprises 516 unique OPA1 variants, of which
more than 80% (414) are considered pathogenic. Full clinical data for 118 patients
are documented using the Human Phenotype Ontology, a standard vocabulary for
referencing phenotypic abnormalities. Contributors may now make online
submissions of phenotypes related to OPA1 mutations, giving clinical and molecular
descriptions together with detailed ophthalmological and neurological data,
according to an international thesaurus.
CONCLUSIONS: The evolution of the OPA1 database towards the LOVD, using
unified nomenclature, should ensure its interoperability with other databases and
prove useful for molecular diagnoses based on gene-panel sequencing, large-scale
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